Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Part I: clinical practice guidelines for children with Down syndrome from birth to 12 years.

Literature DB >> 16399479

Part I: clinical practice guidelines for children with Down syndrome from birth to 12 years.

Susan N Van Cleve¹, William I Cohen.

Abstract

Entities: Species

Mesh：

Year: 2006 PMID： 16399479 DOI： 10.1016/j.pedhc.2005.10.004

Source DB: PubMed Journal: J Pediatr Health Care ISSN： 0891-5245 Impact factor: 1.812

Keyword Cloud
Cited

× No keyword cloud information.

22 in total

1. Disruption of bone development and homeostasis by trisomy in Ts65Dn Down syndrome mice.

Authors: Joshua D Blazek; Anna Gaddy; Rachel Meyer; Randall J Roper; Jiliang Li
Journal: Bone Date: 2010-09-24 Impact factor: 4.398

2. What I wish I knew then...reflections from personal experiences in counseling about Down syndrome.

Authors: Campbell K Brasington
Journal: J Genet Couns Date: 2007-08-13 Impact factor: 2.537

3. A neural crest deficit in Down syndrome mice is associated with deficient mitotic response to Sonic hedgehog.

Authors: Randall J Roper; Justin F VanHorn; Colyn C Cain; Roger H Reeves
Journal: Mech Dev Date: 2008-11-21 Impact factor: 1.882

4. Vitamin supplement use among children with Down's syndrome and risk of leukaemia: a Children's Oncology Group (COG) study.

Authors: Cindy K Blair; Michelle Roesler; Yang Xie; Alan S Gamis; Andrew F Olshan; Nyla A Heerema; Leslie L Robison; Julie A Ross
Journal: Paediatr Perinat Epidemiol Date: 2008-05 Impact factor: 3.980

5. Epigallocatechin-3-gallate (EGCG) consumption in the Ts65Dn model of Down syndrome fails to improve behavioral deficits and is detrimental to skeletal phenotypes.

Authors: Megan Stringer; Irushi Abeysekera; Jared Thomas; Jonathan LaCombe; Kailey Stancombe; Robert J Stewart; Karl J Dria; Joseph M Wallace; Charles R Goodlett; Randall J Roper
Journal: Physiol Behav Date: 2017-05-03

Part I: clinical practice guidelines for children with Down syndrome from birth to 12 years.

1. Disruption of bone development and homeostasis by trisomy in Ts65Dn Down syndrome mice.

2. What I wish I knew then...reflections from personal experiences in counseling about Down syndrome.

3. A neural crest deficit in Down syndrome mice is associated with deficient mitotic response to Sonic hedgehog.

4. Vitamin supplement use among children with Down's syndrome and risk of leukaemia: a Children's Oncology Group (COG) study.

5. Epigallocatechin-3-gallate (EGCG) consumption in the Ts65Dn model of Down syndrome fails to improve behavioral deficits and is detrimental to skeletal phenotypes.

6. Trisomic and allelic differences influence phenotypic variability during development of Down syndrome mice.

7. Congenital abnormalities and acute leukemia among children with Down syndrome: a Children's Oncology Group study.

Review 8. Celiac disease: pathophysiology, clinical manifestations, and associated autoimmune conditions.

9. Complex contributions of Ets2 to craniofacial and thymus phenotypes of trisomic "Down syndrome" mice.

10. PCR prescreen for genotyping the Ts65Dn mouse model of Down syndrome.